FRANKFURT/PARIS (dpa-AFX Broker) - Shares of Sartorius and its subsidiary Sartorius Stedim came under pressure on Monday following an analyst report by Morgan Stanley. Preferred shares of Sartorius slid more than 3 percent to 329 euros, approaching the recent low for the year of 324.40 euros again. Stedim lost 2.5 percent to 239.40 euros in Paris.

Expert James Quigley removed his recommendations for Sartorius' preferred shares, which are listed on the Dax, as well as for its ordinary shares. He now rates both as "Equal-weight" only, with a target price of 375 euros for the preference shares. For Stedim, in which the Gottingen-based group holds almost 74 percent of the shares, Quigley cut his price target to 285 euros.

The Morgan Stanley analyst expects the destocking in the bioprocess sector to drag on into the fourth quarter. He also wants more clarity on the financing of the recently announced acquisition of Polyplus./ag/mis